I am looking to initiate relationships with debt and equity providers.

We are working through several pre-LOI deals right now ranging from $2-20M EBITDA in the healthcare space. We have extensive resources and capacity to execute pre-close DD and post-close growth mandates.

As a North American lower middle market healthcare consolidation and innovation platform serving aging and chronically ill populations, New Health Investment Group (“New Health” or “NHIG”) is creating the healthcare system of the future by consolidating healthcare services and technology that improve health outcomes and healthcare system efficiencies.

The New Health team holds over 200 years of experience, and combined, has closed hundreds of deals totaling tens of billions in enterprise value. New Health brings together extensive experience in private equity, venture capital, due diligence, finance, law, strategy, science, data, technology, digital transformation, and operations across the healthcare continuum.

We intend to acquire companies at purchase prices between 3-10x EBITDA at an average of 6x. We expect to achieve an exit multiple of 10x within the following 5 years via strategic sale or IPO, which we believe is conservative given that the industry average exit multiple is above 12x. At these metrics, we expect to achieve above 30% IRR’s for our equity investors.